Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02406300Terminated
Randomised trial of ropivacaine, sevoflurane and desflurane in Hip fracture (2 arms). Primary endpoint: Survival rate at 1 year. Started Apr 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02406300.